Frequency and clinical significance of β-subunit human chorionic gonadotropin expression in non-small cell lung cancer patients

Tumor Biology

Volumn 20, Issue 2, 1999, Pages 99-104

  Szturmowicz, Monika ^a   Slodkowska, J ^a   Zych, J ^a   Rudzinski, P ^a   Sakowicz, A ^a   Rowinska Zakrzewska, E ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Chorionic blood; Gonadotropins; Immunohistochemistry; Lung carcinoma

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; AGED; ARTICLE; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032998591     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030052     Document Type: Article

References (29)

1. Agnatis NJ, Patra F, Khaldi L, Filis S: Immunohistochemical expression of subunit beta HCG in breast cancer. Eur J Gynaecol Oncol 1992;13: 461-466.
2. Alfthan H, Haglund C, Roberts P, Stenman UH: Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992;552:4628-4633.
3. Connelly JH, Johnston DA, Bruner JM: The prognostic value of human chorionic gonadotropin expression in colorectal adenocarcinomas. An immunohistochemical study of 102 stage B2 and C2 nonmucinous adenocarcinomas. Arch Pathol Lab Med 1993;117:824-826.
4. Marcillac I, Troalen F, Bidart JM, Ghilliani P, Escudier B, Malassagne B, Droz JP, Lhomme C, Rougier P: Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res 1992; 52:3901-3907.
5. Marcillac I, Cottu P, Theodore C, Terrier-Lacombe M-J, Bellet D, Droz J-P: Free hCG-β6 subunit as tumor marker in urothelial cancer. Lancet 1993;341:1354-1355.
6. Neven P, Iles RK, Lee CL, Hudson CN, Shepherd JH, Chard T: Urinary chorionic gonadotropin subunits and beta-core in nonpregnent women. Cancer 1993;71:4124-4130.
7. Manzi D, Greenberg B, Maier D, Forouhar F, Malchoff CD: Bronchogenic carcinoma presenting as a pseudopregnancy. Chest 1995;107: 567-569.
8. Miyake M, Ito M, Mitsuoka A, Taki T, Wada H, Hitomi S, Kino T, Matsui Y: Alpha-fetoprotein and human chorionic gonadotropin-producing lung cancer. Cancer 1987;59:227-232.
9. Smith LG, Lyubsky SL, Carlson HE: Postmenopausal uterine bleeding due to estrogen production by gonadotropin-secreting lung tumors. Am J Med 1992;92:327-330.
10. Boucher LD, Yoneda K: The expression of trophoblastic cell markers by lung carcinomas. Hum Pathol 1995; 26:1201-1206.
11. Heyderman E, Chapman D, Richardson TC, Calvert I, Rosen SW: Human chorionic gonadotropin and human placental lactogen in extra-gonadal tumors. Cancer 1985;56: 2674-2682.
12. Kimura M, Ghandur-Mnaymen L: An immunohistochemical study of keratin, carcinoembryotic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer. Tohoku J Exp Med 1985;145:23-38.
13. Slodkowska J, Szturmowicz M, Rudzinski P, Giedronowicz D, Sakowicz A, Androsiuk W, Rowinska-Zakrzewska E: Expression of CEA and trophoblastic cell markers by lung carcinomas in association with histological characteristics and serum marker levels. Eur J Cancer Prev 1998;7:51-60.
14. Szturmowicz M, Wiatr E, Sakowicz A, Slodkowska J, Roszkowski K, Filipecki S, Rowinska-Zakrzewska E: The role of human chorionic gonadotropin beta subunit elevation in small-cell lung cancer patients. J Cancer Res Clin Oncol 1995;121: 309-312.
15. The World Health Organization histological typing of lung tumours. Second edition. Am J Clin Pathol 1982;77:123-136.
16. Mountain CF: Staging of lung cancer: The new international system. Lung Cancer 1987;3:4-11.
17. WHO Handbook for Reporting Results of Cancer Treatment. WHO offset publication No 48. Geneva, World Health Organisation, 1979.
18. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 1981;29:557-580.
19. Broniek A, Ochnio J, Roginska E, Kwiek S, Rowinska-Zakrzewska E: Occurrence of increased levels of human chorionic gonadotropin alpha and beta subunits in sera of patients with primary carcinoma of the lung. Pneumonol Pol 1986;54: 348-352.
20. Buccheri GF, Violante B, Sartoris AM, Ferrigno D, Curcio A, Vola F: Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma. Cancer 1986; 57:2389-2396.
21. Groop C, Havemann K, Scheuer A: Ectopic hormones in lung cancer patients at dignosis and during therapy. Cancer 1980;46:347-354.
22. Kozlowicz-Gudzinska I, Pietraszek A, Kaminska J: Initial concentration of neoplastic biological markers AFP (alphafetoprotein), HCG (choriongonadotropin), SP1 (specific pregnancy protein in separate types and stages of clinical advancement of lung cancer. Nowotwory 1989;39: 162-165.
23. Walop W, Chretien M, Colman NC, Fraser RS, Gilbert F, Hidvegi RS, Hutchinson T, Kelly B, Lis M, Spitzer WO, Suissa S: The use of biomarkers in the prediciton of survival in the patients with pulmonary carcinoma. Cancer 1990;65:2033-2046.
24. Harach HR, Skinner M, Gibbs AR: Biological markers in human lung carcinoma: An immunopathological study of six antigens. Thorax 1983; 8:937-941.
25. Kuida CA, Braunstein GD, Shintaku P, Said JW: Human chorionic gonadotropin expression in lung, breast, and renal carcinomas, Arch Pathol Lab Med 1988;112:282-285.
26. Bepler G, Jaques G, Oie HK, Gazdar AF: Human chorionic gonadotropin and related glycoprotein hormones in lung cancer cell lines. Cancer Lett 1991;58:145-150.
27. Acevedo HF, Krichevsky A, Campbell-Acevedo EA, Galyon JC, Buffo MJ, Hartsock RJ: Expression of membrane-associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells. Cancer 1992;69:1829-1842.
28. Acevedo HF, Hartsock RJ: Metastatic phenotype correlates with high expression of membrane-associated complete β-human chorionic gonadotropin in vivo. Cancer 1996; 78:2388-2399.
29. Kardana A, Braunstein GD, Cole LA: Gonadotropin beta-subunit nicking enzyme (GBNE), a potential marker of early malignancies. Oncol Res 1996;8:13-16.